Cite
North ML, Walker TJ, Steacy LM, et al. Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit. Allergy Asthma Clin Immunol. 2014;10(1):33doi: 10.1186/1710-1492-10-33.
North, M. L., Walker, T. J., Steacy, L. M., Hobsbawn, B. G., Allan, R. J., Hackman, F., Sun, X., Day, A. G., & Ellis, A. K. (2014). Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 10(1), 33. https://doi.org/10.1186/1710-1492-10-33
North, Michelle L, et al. "Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit." Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology vol. 10,1 (2014): 33. doi: https://doi.org/10.1186/1710-1492-10-33
North ML, Walker TJ, Steacy LM, Hobsbawn BG, Allan RJ, Hackman F, Sun X, Day AG, Ellis AK. Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit. Allergy Asthma Clin Immunol. 2014 Jul 03;10(1):33. doi: 10.1186/1710-1492-10-33. eCollection 2014. PMID: 25024716; PMCID: PMC4094756.
Copy
Download .nbib